Symbols

SRGA(Delisted)

Surgalign·NASDAQ

--(--)

Key Stats

0.0000DAY`S RANGE0.0000

0.000052 WK RANGE0.0000

Open

0.0000

Prev.Close

0.0000

%Range

Turnover

Avg Vol(4W)

Market Cap

Div.Yield

P/E(TTM)

EPS(TTM)

Beta

Free Float

Shares Outstanding

%Turnover

P/E(DYN)

P/B

BVPS

High

0.0000

Low

0.0000

52 Week High

0.0000

52 Week Low

0.0000

About SRGA

Surgalign Holdings, Inc.

A global medical technology company focused on elevating the standard of care by driving the evolution of digital surgery

Industry

Established Date

Listing Date

03/11/2019

Exchange

NASDAQ Stock Exchange

Full-time Employees

217

Fiscal Year Ends

12-31

Website

www.surgalign.com

Security Type

Common stock

Office address

520 Lake Cook Road, Suite 315, Deerfield, Illinois 60015

Business

Introduction

Surgalign Holdings, Inc., was founded in Florida in 1997. The company is a global surgical implant company that designs, develops, manufactures and distributes biological, metal and synthetic implants. The company's implants can be used in plastic surgery, spine, sports medicine, plastic surgery, trauma and other surgical procedures to repair and promote the natural healing of human bones and other human tissues, and to improve surgical outcomes.

Company Financials

EPS

SRGA has released its 2023 Q1 earnings. EPS was reported at -0.9, versus the expected -0.9, meeting expectations. The chart below visualizes how SRGA has performed over recent quarters, highlighting trends in earnings surprises.

Revenue & Expenses

SRGA has released its 2023 Q1 earnings report, with revenue of 16.75M, reflecting a YoY change of -18.72%, and net profit of 4.14M, showing a YoY change of 15251.85%. The Sankey diagram below clearly presents SRGA's revenue sources and cost distribution.